Literature DB >> 3463606

Intensive therapy for life-threatening medical complications of haematological malignancy.

A R Lloyd-Thomas, H S Dhaliwal, T A Lister, C J Hinds.   

Abstract

The medical records of 22 consecutive adult admissions to an intensive care unit (ICU) with life-threatening complications of haematological malignancy, or its treatment, are reviewed. Twenty patients (91%) were in acute respiratory failure, and 17 of the 22 patients required intermittent positive pressure ventilation (IPPV). The in-unit mortality was 55%, but only 4 patients (18%) survived to leave the hospital. Although the unit mortality appeared to be related to the acute physiology score (APS), this small series did not demonstrate a clear relationship between the APS and long-term survival (discharge from hospital). There were, however, significant differences in the number of organ systems involved between those who died on the ICU and those who returned to the ward, as well as between those who survived to leave hospital and those who died. No patient with more than three systems involved became a long-term survivor. All long-term survivors had either reasonable peripheral white cell counts throughout or their bone marrow showed significant recovery prior to discharge from the ICU. Unresponsive malignant disease and a failure to recover bone marrow function were major factors in those patients who died shortly after discharge from the ICU. Although long-term survival rates are low and are probably largely determined by the progress of the underlying malignancy, intensive care was life-saving in four patients, three of whom are alive several years after discharge.

Entities:  

Mesh:

Year:  1986        PMID: 3463606     DOI: 10.1007/BF00261745

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  The role of an intensive care unit in a cancer center. An analysis of 1035 critically ill patients treated for life-threatening complications editorial.

Authors:  A Turnbull; P Goldiner; D Silverman; W Howland
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

2.  A comparison of intensive care in the U.S.A. and France.

Authors:  W A Knaus; J R Le Gall; D P Wagner; E A Draper; P Loirat; R A Campos; D J Cullen; M K Kohles; P Glaser; C Granthil; P Mercier; F Nicolas; P Nikki; B Shin; J V Snyder; F Wattel; J E Zimmerman
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

Review 3.  "Bad risk" non-Hodgkin lymphomas.

Authors:  A Horwich; M Peckham
Journal:  Semin Hematol       Date:  1983-01       Impact factor: 3.851

4.  Short-term treatment for acute myelogenous leukaemia.

Authors:  R Bell; A Z Rohatiner; M L Slevin; J M Ford; H S Dhaliwal; G Henry; B G Birkhead; J A Amess; J S Malpas; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-24

5.  Evaluating outcome from intensive care: a preliminary multihospital comparison.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman; M L Birnbaum; D J Cullen; M K Kohles; B Shin; J V Snyder
Journal:  Crit Care Med       Date:  1982-08       Impact factor: 7.598

6.  Inappropriate use of intensive care.

Authors:  B Jennett
Journal:  Br Med J (Clin Res Ed)       Date:  1984 Dec 22-29

7.  The inverse relationship between cost and survival in the critically ill cancer patient.

Authors:  A D Turnbull; G Carlon; R Baron; W Sichel; C Young; W Howland
Journal:  Crit Care Med       Date:  1979-01       Impact factor: 7.598

8.  Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy.

Authors:  D P Schuster; J M Marion
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

9.  Survival of patients with cancer in a medical critical care unit.

Authors:  M J Hauser; J Tabak; H Baier
Journal:  Arch Intern Med       Date:  1982-03

10.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

View more
  17 in total

1.  Intensive care: who should decide?

Authors:  P Sundström
Journal:  Health Care Anal       Date:  1994-02

2.  Has survival increased in cancer patients admitted to the ICU? Yes.

Authors:  Djamel Mokart; Stephen M Pastores; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-08-27       Impact factor: 17.440

3.  Pneumoperitoneum as a sign of pulmonary barotrauma during artificial ventilation.

Authors:  H J du Plessis; H J Ingram
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study.

Authors:  Matthieu Schmidt; Peter Schellongowski; Nicolò Patroniti; Fabio Silvio Taccone; Dinis Reis Miranda; Jean Reuter; Helène Prodanovic; Marc Pierrot; Amandine Dorget; Sunghoon Park; Martin Balik; Alexandre Demoule; Ilaria Alice Crippa; Alain Mercat; Philipp Wohlfarth; Romain Sonneville; Alain Combes
Journal:  Am J Respir Crit Care Med       Date:  2018-05-15       Impact factor: 21.405

5.  Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit.

Authors:  Radoslaw Owczuk; Magdalena A Wujtewicz; Wioletta Sawicka; Anna Wadrzyk; Maria Wujtewicz
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

6.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Outcomes in critically ill chronic lymphocytic leukemia patients.

Authors:  Aliénor Xhaard; Loic Epelboin; David Schnell; François Vincent; Vincent Levy; Marion Malphettes; Elie Azoulay; Michaël Darmon
Journal:  Support Care Cancer       Date:  2013-02-15       Impact factor: 3.603

8.  Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study.

Authors:  Amanda L Roze des Ordons; Kris Chan; Imran Mirza; Derek R Townsend; Sean M Bagshaw
Journal:  BMC Cancer       Date:  2010-09-28       Impact factor: 4.430

9.  Early tracheotomy in neutropenic, mechanically ventilated patients: rationale and results of a pilot study.

Authors:  F Blot; M Guiguet; S Antoun; B Leclercq; G Nitenberg; B Escudier
Journal:  Support Care Cancer       Date:  1995-09       Impact factor: 3.603

10.  Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; I Wright; T A Lister; C J Hinds
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.